COMPANY PROFILE -Cipla Ltd.
Business Sector :Pharmaceuticals
Operating Geography :India, Asia, Global
About Cipla Ltd. :
Cipla Limited is a pharmaceutical company headquartered in Mumbai, India and having operations in around 80 countries in the world. It was founded in the year 1935 and has rich experience of over 80 years in the pharma sector. The company primarily is into making pills to treat and cure aliments and is also involved in developing medical devices and therapeutics. The company excels in developing devices to treat respiratory issues, cardiovascular diseases, arthritis, diabetes, weight control and depression treatment. India is the largest market and also the largest source of revenue for the company whereas the US market being at the second position for Cipla. Cipla aims to become the largest seller through strategic plans and by emerging into new markets with high potential. As of 2023, Cipla employed around 40,000 people. Cipla has won various awards and accolades such as 'Company of the Year' award at the Business Standard Annual Awards 2021, ‘FICCI CSR Award’ 2019-20 under the ‘Health’ category, and so on.
The USP of Cipla lies in it being India’s 3rd largest and South Africa’s 3rd largest private pharmaceutical company. Cipla’s mission is “to be a leading global healthcare company which uses technology and innovation to meet every day needs of all patients.”
Cipla Ltd. Revenue :
INR 21,763 crores - FY ending 31st March 2022
INR 19,160 crores - FY ending 31st March 2021
Competitive Analysis of Cipla Ltd.
The SWOT analysis for Cipla is presented below in a matrix followed by the detailed analysis report:
| Strengths | Weaknesses |
1. Reputed brand with strong product portfolio with leading share in respiratory and AVR’s category
2. Consistently strong financial performance and growth
3. Experienced management and promoters with established track record
4. Innovation through digitization and online platforms
5. Lung segment leadership across markets
6. Diversified manufacturing and operational presence
7. Strengthening position in South Africa and Emerging Markets
| 1. Coming with tag of Generics giant
2. Limited presence in developed countries
3. Regulatory risks and warnings from USFDA
4. Allegations of tax violations
|
| Opportunities | Threats |
1. Post pandemic global view and scope
2. Stretching footprint into developed countries
3. AI and digital analytics to play an increasing role in pharma
4. Unlocking of Respiratory franchise in the US
5. Strategic partnerships and acquisitions to drive growth
6. Launch of testing devices and new segment to expand business
| 1. Constant evolution or changes in the drug pricing method in India by authorities
2. Strong competition at domestic level with limited market share
3. Dependence on China for raw materials
|
On purchase the Cipla Ltd SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 4 hours might be caused.
Detailed SWOT Analysis of Cipla Ltd.
Strength
1. Strong product portfolio with leading share in respiratory and AVR’s category: Cipla’s product portfolio consists mainly of generic products total about 1,500 products in 65 therapeutic categories and over 50 dosage forms. It has 47 manufacturing across 80+ countries. Majority of the revenue contribution comes from India, USA, and South Africa. Cipla’s product portfolio spans various therapeutic areas including respiratory, anti-infectives, cardio-metabolic, urology, gastro-intestinal etc. The Company has been further strengthening the portfolio in therapies such as diabetology, women’s health, IVF and oncology. Cipla's South Africa private business introduced 32 new products in several therapeutic categories during fiscal year 2021-22. Cipla had the greatest number of new product launches in the market in March 2022, according to IQVIA MAT data. Cipla is positioned for future development as a result of these launches, which targeted a total market size of more than ZAR 3.0 billion. Cipla holds 2nd position in world for inhaler sales by volume. Cipla known for bringing world’s first ever paradigm changing triple anti-retroviral therapy (Stavudine + Lamivudine + Nevirapine) in the treatment of HIV/AIDS in 2001. This breakthrough invention was made affordable and available to all at less than a ‘Dollar a Day’ brought down the treatment cost from $12,000 to $300 per year. Cipla also has its products into biosimilars and consumer healthcare category.
2. Consistently strong financial performance and growth: Cipla has major revenue share contribution from India, followed by Africa and North America. From past 5 years Cipla has showed positive growth revenue from INR 14,630 Cr to INR 21,763 Cr with CAGR of 8%. The EBIDTA has shown consistent increase from INR 2480 crore in FY15-16 to INR 4,578 crore in FY21-22 – recording 13% five-year CAGR. Profit After Tax (PAT) stood at INR 2,517 crore in FY21-22 recording 20% CAGR over the last five-year period. Strong free cash flows allowed Cipla to maintain a healthy net debt-to-equity, improving to 0.05 in FY21-22 from 0.11 in FY 2020-21. Above mentioned all financial data add as feathers to say that CIPLA is one of the strongest financially sustainable company.
The remaining section under "Strength" is available only in the 'Complete Report' on purchase.
Weakness
This section is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
The PESTLE analysis for Cipla is presented below in a table followed by the detailed analysis report.
| Political | Economical |
1. Government’s focus on improving ease of doing business and formulating policies to aid pharma industry
2. Geopolitical volatility increasing business risks
3. Impact of Russia-Ukraine war on the pharma industry
| 1. Global medicine market is projected to grow at 3-6% annually
2. Macroeconomic headwinds are expected to increase
|
| Social | Technological |
| 1. Building direct patient connect (B2C) with increasing digital adoption | 1. Digital transformation strategy to fuel business growth:
2. Digital therapeutics – a segment with growing opportunity
3. Revolutionizing manufacturing processes through Industry 4.0
|
| Legal | Environmental |
1. Increasingly evolving global regulatory environment
2. Engagement with regulatory bodies and other stakeholders
| 1. Strong focus on Environment, Health & Safety (EHS) and Sustainability
2. Leveraging renewable energy and Agri-waste
|
On purchase the Cipla Ltd SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 4 hours might be caused.
Detailed Pestle Analysis of Cipla Ltd.
Political
1. Government’s focus on improving ease of doing business and formulating policies to aid pharma industry: As the world continues to fight the battle with Covid-19, investment is being highly demanded by the pharma companies globally and in India. Cipla being a forerunner in the sector has urged the government to increase its spending in healthcare sector. Also, the company has emphasized on the fact to ease the way of doing pharma business in the country. The current norms served to be hurdles and obstacles and not major checks upon the industry. The company has requested to ease norms which would enable the company to scale up its business and serve well during this Covid fight.
The remaining section under "Political" is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
This section is available only in the 'Complete Report' on purchase.
Technological
This section is available only in the 'Complete Report' on purchase.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
Major Competitors :
- Sun Pharmaceutical Industries Ltd
- Dr. Reddy's Laboratories Ltd.
- Divi's Laboratories,
- Aurobindo Pharma,
- Torrent Pharmaceuticals,
- Lupin Ltd,
- Zydus Cadila Healthcare,
On purchase the Cipla Ltd SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 4 hours might be caused.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of Cipla Ltd.:
-
| Cipla Ltd. Porter's Five Forces Analysis |
|
-
-
| Cipla Ltd. Value Chain Analysis |
|
-
| Cipla Ltd. Covid-19 Impact Analysis |
|
-
-
| Cipla Ltd. Segmentation, Targeting and Positioning (STP) Analysis |
|
-
| Cipla Ltd. Ansoff Matrix Analysis |
|
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in Cipla Ltd. SWOT & PESTLE Analysis Report
1. Cipla Annual Report 2021-22 - https://www.cipla.com/sites/default/files/Annual-Report-2021-22-single-page.pdf
2. Press Release - https://www.careratings.com/upload/CompanyFiles/PR/24022021061245_Cipla_Limited.pdf
3. Respiratory Therapies - Asthma | COPD | Nebulization – Cipla - https://www.cipla.com/our-offerings/our-therapies/respiratory
4. About Us - https://www.cipla.com/about-us/
5. Cipla launches diagnostic device for multiple health conditions- https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-launches-diagnostic-device-for-multiple-health-conditions/articleshow/97079810.cms
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
Cipla Ltd SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2023). Cipla Ltd SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/cipla/ [Accessed 23 Sep, 2023].
In-text: (SWOT & PESTLE.com, 2023)
Copyrights and Disclaimer
Cipla Ltd. SWOT and PESTLE analysis has been conducted and reviewed by senior analysts from Barakaat Consulting.
Copyright of Cipla Ltd. SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.
Safe and secure payments
